BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10402006)

  • 1. The reversibility of cardiac neuronal function after removal of a pheochromocytoma: an I-123 MIBG Scintigraphic Study.
    Agostini D; Darlas Y; Filmont JE; Dronne F; Babatasi G; Grollier G; Potier JC; Bouvard G
    Clin Nucl Med; 1999 Jul; 24(7):514-8. PubMed ID: 10402006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cardiac sympathetic nerve function in a patient with pheochromocytoma. An analysis using 123I metaiodobenzylguanidine scintigraphy.
    Izumi C; Himura Y; Konishi T
    Int J Cardiol; 1995 Jun; 50(2):189-92. PubMed ID: 7591331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [123I-metaiodobenzylguanidine myocardial scintigraphy in a case of pheochromocytoma before and after resection of it].
    Matsumoto K; Sugihara H; Ito K; Terada K; Taniguchi Y; Ohtsuki K; Nakata T; Ushijima Y; Maeda T; Nakagawa M
    Kaku Igaku; 1995 Sep; 32(9):1023-8. PubMed ID: 8523838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
    Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
    Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of cardiac neuronal function in acute myocarditis: iodine-123-MIBG scintigraphy study.
    Agostini D; Babatasi G; Manrique A; Saloux E; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 1998 Nov; 39(11):1841-4. PubMed ID: 9829567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
    van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remission of metastatic pheochromocytoma in
    Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
    BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
    Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
    Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131-MIBG scintigraphy in adults: interpretation revisited?
    Roelants V; Goulios C; Beckers C; Jamar F
    J Nucl Med; 1998 Jun; 39(6):1007-12. PubMed ID: 9627334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
    Yokoyama H; Tsuji Y
    Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory uptake of I-123 MIBG in the contralateral adrenal gland after removal of a pheochromocytoma.
    Boersma HH; Wensing JW; Kho TL; De Brauw LM; Liem IH; Van Kroonenburgh MJ
    Clin Nucl Med; 2002 Feb; 27(2):113-6. PubMed ID: 11786741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome.
    Otsuka N; Ohi M; Chin K; Kita H; Noguchi T; Hata T; Nohara R; Hosokawa R; Fujita M; Kuno K
    J Nucl Med; 1997 Apr; 38(4):567-72. PubMed ID: 9098203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.
    Nakajo M; Shapiro B; Glowniak J; Sisson JC; Beierwaltes WH
    J Nucl Med; 1983 Dec; 24(12):1127-34. PubMed ID: 6644373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkable improvement of myocardial metaiodobenzylguanidine uptake after surgery in a patient with pheochromocytoma-a case report.
    Konno T; Araki T; Soma R; Takimoto H; Tofuku Y; Shimizu M
    Angiology; 2004; 55(5):565-7. PubMed ID: 15378121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.
    Nielsen JT; Nielsen BV; Rehling M
    Clin Nucl Med; 1996 Sep; 21(9):695-9. PubMed ID: 8879869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.
    Verberne HJ; de Bruin K; Habraken JB; Somsen GA; Eersels JL; Moet F; Booij J; van Eck-Smit BL
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):483-90. PubMed ID: 16425032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.